Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Cramer Touts -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (26)	8/3/2005 4:16:04 AM
From: Mark099	Respond to of 843

Other CDN oil sands plays are... CNQ.TO Canadian Natural Resources HSE.TO Husky Energy PCA.TO Petro-Canada and, of course, ECA.TO EnCana I have owned CNQ (up 183%) since 2002 and HSE (up 140%) since 2004. I have taken profits in CNQ and moved to other Oil and Gas plays... SPN.UN.TO StarPoint Energy Trust, and PD.TO Precision Drilling I looked at NOV (National-Oilwell Varco) today, but in the end Precision Drilling is a little bit cheaper with a P/E of 24 (vs. 37 for NOV).

To: Ron who wrote (26)	8/3/2005 10:06:09 AM
From: ~digs	Read Replies (1) \| Respond to of 843

Syneron Medical, Ltd. engages in the design, development, and marketing of aesthetic medical products based on its proprietary Electro-Optical Synergy (ELOS) technology. Its ELOS technology combines optical energy, energy derived from light waves, with electrical energy, in particular radiofrequency energy, which results from the flow of electric charge through a conductor. The company’s products, which are sold primarily to physicians and other practitioners, target an array of noninvasive aesthetic medical procedures, including hair removal, wrinkle reduction, and rejuvenating the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, as well as newer applications, including wrinkle reduction, and the treatment of acne and cellulite. stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G Candela Corporation engages in the research, development, manufacture, marketing, and servicing of lasers used to perform procedures addressing patients’ aesthetic, medical, and cosmetic concerns. Its product lines include GentleLASE family of lasers for the treatment of unwanted hair and for the treatment of vascular lesions, pigmented lesions, and wrinkles; Vbeam for the treatment of vascular lesions and wrinkles; ALEXLAZR for the treatment of pigmented lesions and tattoos; Smoothbeam diode laser for non-ablative dermal remodeling of wrinkles, and the treatment of back acne and acne scars; and C-beam pulsed dye laser for treatment of psoriasis and surgical scars. stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G